220 related articles for article (PubMed ID: 21399906)
1. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis.
Miller E; Mrowicka M; Saluk-Juszczak J; Ireneusz M
Neurochem Res; 2011 Jun; 36(6):1012-6. PubMed ID: 21399906
[TBL] [Abstract][Full Text] [Related]
2. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
Piłacik B; Nofer TW; Wasowicz W
Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
[TBL] [Abstract][Full Text] [Related]
3. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
Greco A; Minghetti L
Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
[TBL] [Abstract][Full Text] [Related]
4. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.
Greco A; Minghetti L; Levi G
Neurochem Res; 2000 Oct; 25(9-10):1357-64. PubMed ID: 11059806
[TBL] [Abstract][Full Text] [Related]
5. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
Roberts LJ; Morrow JD
Cell Mol Life Sci; 2002 May; 59(5):808-20. PubMed ID: 12088281
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation, isoprostanes and vascular damage.
Minuz P; Fava C; Lechi A
Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
[TBL] [Abstract][Full Text] [Related]
7. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients.
Basu S
Toxicology; 2003 Jul; 189(1-2):113-27. PubMed ID: 12821287
[TBL] [Abstract][Full Text] [Related]
8. The lipid peroxidation in breast cancer patients.
Kedzierska M; Olas B; Wachowicz B; Jeziorski A; Piekarski J
Gen Physiol Biophys; 2010 Jun; 29(2):208-10. PubMed ID: 20577033
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
[TBL] [Abstract][Full Text] [Related]
10. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
Cracowski JL; Durand T; Bessard G
Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
[TBL] [Abstract][Full Text] [Related]
11. Isoprostanes--markers of ischaemia reperfusion injury.
Sakamoto H; Corcoran TB; Laffey JG; Shorten GD
Eur J Anaesthesiol; 2002 Aug; 19(8):550-9. PubMed ID: 12200943
[TBL] [Abstract][Full Text] [Related]
12. F3-Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegans.
Nguyen TT; Aschner M
Curr Protoc Toxicol; 2014 Nov; 62():11.17.1-13. PubMed ID: 25378241
[TBL] [Abstract][Full Text] [Related]
13. Isoprostanes and other markers of peroxidation in atherosclerosis.
Patrignani P; Tacconelli S
Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.
Koch M; Ramsaransing GS; Arutjunyan AV; Stepanov M; Teelken A; Heersema DJ; De Keyser J
J Neurol; 2006 Apr; 253(4):483-7. PubMed ID: 16283096
[TBL] [Abstract][Full Text] [Related]
15. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
Roberts LJ; Fessel JP
Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
[TBL] [Abstract][Full Text] [Related]
16. Measurement of isoprostanes as markers of oxidative stress.
Milatovic D; Montine TJ; Aschner M
Methods Mol Biol; 2011; 758():195-204. PubMed ID: 21815067
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation products as oxidative stress biomarkers.
Niki E
Biofactors; 2008; 34(2):171-80. PubMed ID: 19706982
[TBL] [Abstract][Full Text] [Related]
18. [LC-MS/MS as a method for the determination of isoprostanes: a brief review].
Król MB; Brzeźnicki S
Med Pr; 2023 May; 74(2):119-125. PubMed ID: 36946654
[TBL] [Abstract][Full Text] [Related]
19. [Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].
Berbecki J; Mitosek-Szewczyk K; Kurzepa J; Nastaj M; Łobejko K; Stelmasiak Z
Wiad Lek; 2011; 64(1):31-6. PubMed ID: 21812361
[TBL] [Abstract][Full Text] [Related]
20. Potential applications of lipid peroxidation products - F
De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
